Interleukin-17A promotes IgE production in human B cells

Area of Science:

• Immunology
• Allergy Research
• Cellular Biology

Background:

• The Th1/Th2 paradigm has evolved, implicating T helper 17 (Th17) cells in allergic responses.
• The precise mechanisms linking elevated IL-17A and IgE in allergy remain unclear.

Purpose of the Study:

• To elucidate the cellular and molecular basis of IL-17A's role in IgE production in allergic patients.
• To investigate IL-17A as a direct mediator of IgE synthesis and its potential as a therapeutic target.

Main Methods:

• Flow cytometry to quantify IL-17A+ cells and analyze intracellular signaling pathways (NF-κB, IκBα).
• Enzyme-linked immunosorbent assay (ELISA) to measure IgE levels.
• Selective cell depletion and recombinant protein re-addition experiments.
• Enzyme-linked immunospot (ELISPOT) assay and quantitative real-time RT-PCR to assess B cell differentiation and gene expression.

Main Results:

• Allergic patients exhibit higher numbers of IL-17A+ cells compared to healthy individuals.
• Depletion of IL-17A+ cells reduces IgE levels, while IL-17A addition restores them.
• IL-17A directly enhances IgE secretion by B cells, promoting key gene transcription (epsilon germ-line, AID, IRF4) via NF-κB activation.
• IL-17A triggers IκBα degradation and NF-κB nuclear translocation in B cells.

Conclusions:

• IL-17A+ cells significantly contribute to IgE production in allergic conditions.
• IL-17A directly acts on B cells to promote IgE synthesis, highlighting its pro-allergic function.
• IL-17A represents a potential therapeutic target for managing IgE-mediated allergic diseases, including atopic dermatitis.